Acorda Therapeutics completes sales foce expansion

Share this article:
Acorda Therapeutics has completed the expansion of its sales force to 65 people, with 52 area business managers, calling on specialists and primary care physicians. The sales team promotes Zanaflex Capsules (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.